Investor Relations

“CardioMap is a unique technology that can meet an unmet need in a large and growing market. We feel very confident that we can capitalize on the CardioMap opportunity to increase patient care and create significant shareholder value. In addition to CardioMap, Odyssey has several acquisition targets it is pursuing.”

J. Michael Redmond, President and CEO

Odyssey Group International, Inc. Market Update

  • Loading stock data...

Shares are currently traded on the OTBB (ODYY) and the Company has a significant asset in the CardioMap heart monitoring and screening device. Click on the following link to review the Company’s SEC filings:

Odyssey Filings

For more information on Odyssey Group International, please complete the following contact form and a member of our investor relations team will respond shortly: